Designing a multifunctional staphylokinase variant (SAK-2RGD-TTI) with appropriate thrombolytic activity in vitro.
Habibollah FarajiFatemeh SoltaniMohammad RamezaniHamid Reza SadeghniaReza NedaeiniaHamid Moghimi BenhangiBaratali MashkaniPublished in: Biotechnology letters (2019)
Our findings suggest that SAK-2RGD-TTI has improved therapeutic properties preventing reocclussion. It further confirms that it is practicable to assemble and produce a hybrid multifunctional protein that targets hemostatic process at various stages.